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Acute Kidney Injury S95Methods: Age-associated susceptibility to acute kidney injury was investi-
gated using 3 month-old and 20 month-old 129 mice. The role of SIRT1 in
AKI was examined using SIRT1 heterozygotes. AKI was induced by
cisplatin. Kidney damage was assessed by BUN, kidney histology and
Tunel. Mitochondria were examined by EM. The signaling pathway
involved was explored by microarray and validated by Q-PCR, western
blot and co-IP.
Results: Exposed to cisplatin, 20-month-old mice had more severe AKI than
3-month-old. In ageing mice, kidney NAD+ level was only 30% of that in the
young, accompanied by reduced SIRT1 expression. SIRT1 deficiency also
significantly aggravated cisplatin-induced AKI compared to littermates. Se-
vere mitochondrial dysfunction and cell damage was observed in AKI aged
mice and SIRT1 knockouts. NMN, provided from the same day as cisplatin,
markedly attenuated renal damage induced by cisplatin, whose effect was
substantially reduced in SIRT1 heterozygotes, indicating the protective ef-
fect of NMN was dependent on SIRT1 activity. Microarray suggests that JNK
pathway is critical associated with SIRT1 deficiency. Q-PCR and WB vaildated
JNK activation while Co-IP revealed related mechnism, which invovled inter-
action between SIRT1 and DUSP16.
Conclusion: (1) In aged kidney, NAD+ levels and SIRT1 expression is reduced,
resulting in increased age-associated susceptibility to AKI. (2) Supplementa-
tion of NMN, a NAD+ precursor and a metabolite of a lipid lowering drug
Niacin, rescued cisplatin-induced kidney damage. (3) JUN activation is asso-
ciated with increased renal injury in SIRT1 deficient animals.http://dx.doi.org/10.1016/j.hkjn.2015.09.0600167
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Objective: To analyze the prognostic factors and discuss treatment options
in order to decrease the mortality rate in paraquat poisoning patients.
Methods: 148 cases of paraquat poisoning patients from June 2010 to March
2014 in our hospital were enrolled. The general situation (gender, age), clin-
ical data (dose of paraquat poisoning, interval from poisoning to treatment),
laboratory parameters (blood oxygen, serum creatinine level, glomerular
filtration rate) and treatment regimen (gastric lavage, total dose of cyclo-
phosphamide, total dose of methylprednisolone, frequency of blood perfu-
sion) were retrospectively analyzed.
Results: Of the 148 cases of paraquat poisoning patients, 85 cases survived
and 63 cases died, the survival rate was 57.4%. All cases were divided into
the survival group and the death group. There were no statistical differences
in gender and age between two groups. The paraquat ingestion dose was
lower in the survival group (14.77 18.9 mmHg) than the death group
(41.00 36.1 mmHg; p <0.05). The serum creatinine level and glomerular
filtration rate in admission had statistically significant differences:
85.05 75.9 mmol/L and 116.80 47.6 ml/min in the survival group, and
172.72 182.8 mmol/L and 49.37 52.3 ml/min in the death group (p
<0.05). The total dose of methylprednisolone therapy in the survival group
1.85 1.37 g was significantly higher than in the death group 1.35 1.14 g
(p < 0.05). The gastric lavage or not, total dose of cyclophosphamide treat-
ment and frequency of blood perfusion had no significant differences be-
tween two groups (p > 0.05).
Conclusion: This study found that paraquat ingestion dose, renal function in
admission and total dose of methylprednisolone were important factors
affecting the prognosis of paraquat poisoning patients, high-dose of methyl-
prednisolone therapy can significantly improve survival, the impact on prog-
nosis of cyclophosphamide and hemoperfusion therapy are still pending
further investigation.http://dx.doi.org/10.1016/j.hkjn.2015.09.0610174
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Objective: Acute kidney injury (AKI) is a common and serious clinic syn-
drome. Early diagnosis becomes a key point of AKI treatment. The search
for a better biomarker is now becoming a central issue in AKI field. TIMP-2
and IGFBP7 are both involved in renal tubular epithelial cell cycle arrest
in AKI. And recently, several researches’ reports showed that urine TIMP-2
multiply IGFBP7 is promising as biomarker in predicting AKI.
Methods: Meta analysis was performed to assess the diagnostic value of
urine [TIMP-2]$[IGFBP7] in AKI. Relevant studies were searched from
Pubmed, Elsevier science Direct Database, EMBASE, SpringerLink, Cochrane
Library and clinical research registration website ClinicalTrials.gov. Meta-
analysis methods were used to synthesis sensitivity and specificity and to
construct summary receiver operating characteristic (SROC) curves.
Results: 5 full-text prospective studies and 1 with unknown study design were
enrolled in our meta-analysis. The estimated sensitivity of urine [TIMP-2]$
[IGFBP7] for the diagnosis of AKI was 0.858 (95% CI, 0.802e0.903), and the
specificity was 0.548 (95% CI, 0.506e0.590). The SROC analysis showed an
area under the curve of 0.8389. Subgroup analysis suggested that urine
[TIMP-2]$[IGFBP7] did better in cardiac surgery patients. Small number of
studies and language limitation might affect the evaluation.
Conclusion: Urine [TIMP-2]$[IGFBP7] may be a promising biomarker for early
detection of AKI, especially in patients after cardiac surgery. Its potential value
needs to be validated in large studies and broader spectrum of clinical settings.Figure 1. Forest plot of pooled sensitivity of urine [TIMP-2]$[IGFBP7]. The
red circles and the horizontal lines represent the point estimate and its
95% confidence interval (CI), respectively. The red diamond below repre-
sents the pooled estimate, and the red horizontal line represents the 95%
CI of the pooled estimate.Figure 2. Forest plot of specificity of urine [TIMP-2]$[IGFBP7]. The red circles
and the horizontal lines represent the point estimate and its 95% confidence in-
terval (CI), respectively. The red diamond below represents the pooled esti-
mate, and the red horizontal line represents the 95% CI of the pooled estimate.http://dx.doi.org/10.1016/j.hkjn.2015.09.062
